[go: up one dir, main page]

MX2016011841A - Composiciones topicas de corticosteroides. - Google Patents

Composiciones topicas de corticosteroides.

Info

Publication number
MX2016011841A
MX2016011841A MX2016011841A MX2016011841A MX2016011841A MX 2016011841 A MX2016011841 A MX 2016011841A MX 2016011841 A MX2016011841 A MX 2016011841A MX 2016011841 A MX2016011841 A MX 2016011841A MX 2016011841 A MX2016011841 A MX 2016011841A
Authority
MX
Mexico
Prior art keywords
compositions
topical corticosteroid
corticosteroid compositions
disorders
topical
Prior art date
Application number
MX2016011841A
Other languages
English (en)
Inventor
Kandavalli Sateesh
Sahukar Priyadarshani
Okumu Franklin
Original Assignee
Promius Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promius Pharma Llc filed Critical Promius Pharma Llc
Publication of MX2016011841A publication Critical patent/MX2016011841A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones para la administración tópica de un agente activo comprenden un corticosteroide y un alcohol graso como un aumentador de penetración en la piel, en la forma de rocíos tópicos. Se describen procesos para preparar tales composiciones y métodos para usarlas en el manejo de enfermedades o trastornos de la piel tales como psoriasis, dermatosis, y otras enfermedades o trastornos de la piel asociados.
MX2016011841A 2014-03-11 2015-09-09 Composiciones topicas de corticosteroides. MX2016011841A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461951165P 2014-03-11 2014-03-11
US14/645,338 US20150258119A1 (en) 2014-03-11 2015-03-11 Topical corticosteroid compositions
PCT/US2015/020031 WO2015138650A1 (en) 2014-03-11 2015-03-11 Topical corticosteroid compositions
PCT/US2015/049244 WO2016144381A1 (en) 2014-03-11 2015-09-09 Topical corticosteroid compositions

Publications (1)

Publication Number Publication Date
MX2016011841A true MX2016011841A (es) 2017-02-02

Family

ID=52727460

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016011842A MX381164B (es) 2014-03-11 2015-03-11 Composiciones tópicas de corticosteroides.
MX2016011841A MX2016011841A (es) 2014-03-11 2015-09-09 Composiciones topicas de corticosteroides.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016011842A MX381164B (es) 2014-03-11 2015-03-11 Composiciones tópicas de corticosteroides.

Country Status (13)

Country Link
US (4) US20150258119A1 (es)
EP (2) EP3116473B1 (es)
JP (2) JP6487949B2 (es)
KR (2) KR101930244B1 (es)
CN (1) CN106659682B (es)
AU (2) AU2015229403B2 (es)
BR (1) BR112016021023A2 (es)
CA (2) CA2945943C (es)
EA (2) EA201691808A8 (es)
ES (1) ES2857602T3 (es)
MX (2) MX381164B (es)
WO (2) WO2015138650A1 (es)
ZA (1) ZA201606704B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2473161T3 (en) 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2017091168A1 (en) * 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. A topical spray comprising isoconazole nitrate and difluocortolone valerate
JP6905994B2 (ja) * 2016-01-12 2021-07-21 ノーティック ホールディングス インコーポレイテッド ベタメタゾン経口スプレー製剤及び運動失調の治療への使用方法
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US20180028766A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Touch-free topical spray of halobetasol
CA3037582A1 (en) 2016-09-21 2018-03-29 Avexxin As Pharmaceutical composition
US10543177B2 (en) 2017-04-11 2020-01-28 Kevin Mrohs Composition and method for treating skin conditions
US11620886B2 (en) 2018-02-19 2023-04-04 Invue Security Products Inc. Merchandise security system with inductive charging
JP2022508512A (ja) * 2018-09-28 2022-01-19 ジョエル スタディン ステロイド及び巨大分子の経穴送達
JP7412292B2 (ja) * 2019-07-10 2024-01-12 積水化学工業株式会社 製剤
WO2021080527A1 (en) * 2019-10-24 2021-04-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Topical pharmaceutical compositions containing difluocortolone and isoconazole
WO2021162796A1 (en) * 2020-02-11 2021-08-19 Taro Pharmaceutical Industries Ltd. Compositions comprising desoximetasone and tazarotene
US11382863B2 (en) * 2020-03-04 2022-07-12 Somerset Therapeutics Llc Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid
CN113092601B (zh) * 2021-03-02 2022-12-20 苏州市药品检验检测研究中心 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892856A (en) 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
WO1991008733A1 (en) * 1989-12-20 1991-06-27 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
IT1247529B (it) 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
ATE223202T1 (de) 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
AU2004313285A1 (en) * 2003-12-16 2005-09-29 Foamix Ltd Oleaginous pharmaceutical and cosmetic foam
AR051197A1 (es) * 2004-08-31 2006-12-27 Connetics Australia Pty Ltd Un procedimiento para obtener una microemulsion y sub-micron emulsion y composiciones
CA2756674C (en) * 2004-08-31 2012-04-03 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
ES2539634T3 (es) 2005-04-25 2015-07-02 Dow Pharmaceutical Sciences Uso de una formulación de clobetasol en forma de pulverización para tratar la psoriasis
GB2443162B (en) 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
DK2473161T3 (en) * 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID
US10029013B2 (en) * 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
NL2004437C2 (en) * 2010-03-19 2011-09-20 Forte Iq B V Spray-pumpable comprising composition suitable for topical skin application.
JP5865360B2 (ja) * 2010-06-11 2016-02-17 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． 油分高濃度配合軟化性エアロゾル発泡組成物
CN104540801B (zh) * 2012-08-10 2016-05-18 旭硝子株式会社 碳酸酯化合物及芳香族聚碳酸酯的制造方法
EP2968572A1 (en) * 2013-03-15 2016-01-20 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
US10111956B2 (en) * 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions

Also Published As

Publication number Publication date
WO2016144381A1 (en) 2016-09-15
CA2945943A1 (en) 2015-09-17
KR20170023791A (ko) 2017-03-06
AU2015385750A1 (en) 2016-10-27
CN106659682A (zh) 2017-05-10
AU2015385750B2 (en) 2019-01-31
EP3116473B1 (en) 2020-12-30
EA201691808A1 (ru) 2017-02-28
US20160030450A1 (en) 2016-02-04
EP3197432A1 (en) 2017-08-02
KR101930246B1 (ko) 2018-12-18
EP3197432A4 (en) 2018-10-10
AU2015229403B2 (en) 2019-05-02
EA201691808A8 (ru) 2017-04-28
JP6535735B2 (ja) 2019-06-26
ES2857602T3 (es) 2021-09-29
JP2017508802A (ja) 2017-03-30
AU2015229403A1 (en) 2016-10-27
BR112016021023A8 (pt) 2018-01-30
CA2946201A1 (en) 2016-09-15
US20200230155A1 (en) 2020-07-23
CA2946201C (en) 2020-10-27
WO2015138650A1 (en) 2015-09-17
EP3116473A1 (en) 2017-01-18
US20150258119A1 (en) 2015-09-17
ZA201606704B (en) 2019-07-31
BR112016021023A2 (pt) 2021-09-14
CN106659682B (zh) 2020-12-29
KR101930244B1 (ko) 2018-12-18
EA201692334A1 (ru) 2018-02-28
MX381164B (es) 2025-03-12
CA2945943C (en) 2020-10-27
JP2017530974A (ja) 2017-10-19
JP6487949B2 (ja) 2019-03-20
MX2016011842A (es) 2017-02-02
US20180250312A1 (en) 2018-09-06
KR20160144377A (ko) 2016-12-16

Similar Documents

Publication Publication Date Title
MX2016011841A (es) Composiciones topicas de corticosteroides.
MX2018000421A (es) Composiciones de retinoides topicos.
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
PH12018500586A1 (en) Farnesoid x receptor agonists and uses thereof
WO2011026076A3 (en) Topical formulations comprising a steroid
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
HK1251566A1 (zh) 作为hdac1/2抑制剂的呱啶衍生物
IN2015DN03069A (es)
WO2018106108A8 (en) Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
MY193312A (en) Topical formulation for promoting wound healing
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
PH12014501573A1 (en) Topical pharmaceutical compositions comprising bexarotene and a corticosteroids
ITUB20152862A1 (it) Veicolo per terapia fotodinamica topica con acido delta-aminolevulinico in ambito dermatologico e metodo di preparazione del veicolo stesso.
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
SG10201810362SA (en) Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition
PH12020500472A1 (en) Autotaxin inhibitor compounds
UA92452U (ru) Способ заживления местных лучевых повреждений кожи
UA92219U (ru) Лекарственное средство с метронидазолом для лечения дерматологических заболеваний
IN2014CH01890A (es)